- Home
- APLS vs M Comparison
APLS vs M Comparison
Compare APLS & M Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLS
- M
- Stock Information
- Founded
- APLS 2009
- M 1830
- Country
- APLS United States
- M United States
- Employees
- APLS N/A
- M N/A
- Industry
- APLS Biotechnology: Pharmaceutical Preparations
- M Department/Specialty Retail Stores
- Sector
- APLS Health Care
- M Consumer Discretionary
- Exchange
- APLS Nasdaq
- M Nasdaq
- Market Cap
- APLS 4.4B
- M 4.1B
- IPO Year
- APLS 2017
- M N/A
- Fundamental
- Price
- APLS $33.21
- M $16.47
- Analyst Decision
- APLS Buy
- M Hold
- Analyst Count
- APLS 19
- M 10
- Target Price
- APLS $49.89
- M $18.56
- AVG Volume (30 Days)
- APLS 3.2M
- M 8.4M
- Earning Date
- APLS 11-05-2024
- M 12-11-2024
- Dividend Yield
- APLS N/A
- M 4.29%
- EPS Growth
- APLS N/A
- M N/A
- EPS
- APLS N/A
- M 0.61
- Revenue
- APLS $715,216,000.00
- M $23,374,000,000.00
- Revenue This Year
- APLS $95.59
- M N/A
- Revenue Next Year
- APLS $12.92
- M N/A
- P/E Ratio
- APLS N/A
- M $26.42
- Revenue Growth
- APLS 162.10
- M N/A
- 52 Week Low
- APLS $24.34
- M $14.06
- 52 Week High
- APLS $73.80
- M $22.10
- Technical
- Relative Strength Index (RSI)
- APLS 53.75
- M 49.39
- Support Level
- APLS $32.88
- M $16.18
- Resistance Level
- APLS $35.71
- M $17.23
- Average True Range (ATR)
- APLS 1.60
- M 0.67
- MACD
- APLS -0.22
- M -0.09
- Stochastic Oscillator
- APLS 36.62
- M 55.27
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.
About M Macy's Inc
Founded in 1858 and based in New York City, Macy's operates about 500 stores under the Macy's nameplate, nearly 60 stores under the Bloomingdale's (full-price and outlet) and Bloomie's nameplates, and 157 freestanding Bluemercury specialty beauty stores. Macy's also operates e-commerce sites and licenses Bloomingdale's stores in the United Arab Emirates and Kuwait. Women's apparel, accessories, shoes, cosmetics, and fragrances composed 62% of Macy's 2023 sales.